Skip to content
Fencer Vulns
medium 6.1

CVE-2025-54783 json

SuiteCRM: Reflected Cross Site Scripting (XSS) through HTTP Referrer header

published 2025-08-07 15 mo ago modified 2026-06-17 4 mo ago also EUVD-2025-23894

cvss
6.1
version 3.1, NVD
cisa kev
Not listed
not in CISA's catalog
epss
0.2%
EPSS 0.2% chance of exploitation in 30 days, percentile 15%
public exploits
0
none known

Summary

SuiteCRM is an open-source, enterprise-ready Customer Relationship Management (CRM) software application. Versions 7.14.6 and below have a Reflected Cross-Site Scripting (XSS) vulnerability. This vulnerability allows an attacker to execute JavaScript code by modifying the HTTP Referer header to include some arbitrary domain with malicious JavaScript code at the end. The server will attempt to block the arbitrary domain but allow the JavaScript code to execute. This is fixed in version 7.14.7.

Patch / fix

  • salesagility suitecrm 7.14.7
  • suitecrm suitecrm 7.14.7

CISA SSVC

Exploitation
none
Automatable
no
Technical impact
partial
Assessed
15 mo ago

Exploit prediction

0.24% chance of exploitation in the next 30 days, higher than 15% of all scored CVEs (FIRST EPSS, 2026-11-08).

CVSS scores

assigned by version score vector
CNA 4.0 5.1 CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:A/VC:N/VI:N/VA:N/SC:L/SI:L/SA:N
CNA 4.0 5.1 CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:A/VC:N/VI:N/VA:N/SC:L/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
NVD 3.1 6.1 CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N

Affected products

  • SuiteCRM SuiteCRM

Classification

Weakness
  • CWE-79 Improper Neutralization of Input During Web Page Generation

References

Sources

Fencer Vulns keeps one entry per vulnerability: the CVE id wins, then GHSA, and records that alias each other are merged, except that two CVEs always keep separate entries. The same data is available as JSON.

CPEs and fixed versions use Anchore's correction of NVD's data: Added CPE configurations because not yet analyzed by NVD.